Showing results (31-40 of 65) with videos related to
Sort By:
Pageof 7
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 13, 2007
Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancerS E Duff, M Jeziorska, S Kumar, et al.British Journal of Cancer|September 22, 1998
The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasoneA M Wardley, G C Jayson, D J Goldsmith, et al.Anticancer Research|September 15, 2005
Development of a modified hollow fibre assay for studying agents targeting the tumour neovasculatureS D Shnyder, J Hasan, P A Cooper, et al.British Journal of Cancer|January 23, 2014
Thrombosis in ovarian cancer: a case control studyR L Metcalf, D J Fry, R Swindell, et al.British Journal of Cancer|October 2, 2003
A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinomaA R Clamp, F H Blackhall, P Vasey, et al.ESMO Open|November 16, 2016
Does clinical trial participation improve outcomes in patients with ovarian cancer?L Khoja, L Horsley, A Heesters, et al.British Journal of Cancer|April 18, 2007
Heparan sulphate synthetic and editing enzymes in ovarian cancerA C Backen, C L Cole, S C Lau, et al.British Journal of Cancer|July 31, 2003
Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancyS E Duff, C Li, M Jeziorska, et al.The British Journal of Radiology|April 10, 2003
Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting gliomaA Jackson, G C Jayson, K L Li, et al.British Journal of Haematology|September 6, 2000
Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescueA M Wardley, G C Jayson, R Swindell, et al.Pageof 7